Citation:Righi L, Graziano P, Fornari A, Rossi G, Barbareschi M, Cavazza A, et al 2011

From Cancer Guidelines Wiki

Citation


Righi L, Graziano P, Fornari A, Rossi G, Barbareschi M, Cavazza A, et al. Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation. Cancer 2011 Aug 1;117(15):3416-23 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21246522.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Righi L, Graziano P, Fornari A, Rossi G, Barbareschi M, Cavazza A, et al 2011When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?Associate Professor Wendy Coopercompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Righi_L,_Graziano_P,_Fornari_A,_Rossi_G,_Barbareschi_M,_Cavazza_A,_et_al_2011&oldid=107047"